Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Wednesday, February 08, 2023
BD (Becton, Dickinson and Company) has received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A...
read more
Wednesday, February 01, 2023
Translocation from cytoplasm to nucleus and integration of reverse-transcribed SARS-CoV-2 spike mRNA into the genomic DNA of COVID-19 mRNA-vaccinated individuals positive for HIV-1 or other retroviral...
read more
The FDA revised the Emergency Use Authorization (EUA) for Evusheld (tixagevimab co-packaged with cilgavimab) to limit its use to when the combined frequency of non-susceptible SARS-CoV-2 variants ...
read more
Thursday, December 29, 2022
Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its ...
read more
Thursday, December 22, 2022
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that the companies provided approximately 11,500 doses of mRNA-based COVID-19 vaccines which arrived on the Chinese Mainland ...
read more
Thursday, December 22, 2022
The FDA has approved a new indication for Actemra (tocilizumab) injection for the treatment of hospitalized adult patients with COVID-19 who are receiving systemic corticosteroids and require ...
read more
Thursday, December 22, 2022
Translocation from the cytoplasm to nucleus and integration of reverse-transcribed SARS-CoV-2 spike mRNA into the genomic DNA of COVID-19 mRNA-vaccinated individuals positive for HIV-1 or other ...
read more
Monday, December 12, 2022
Pfizer Canada ULC and BioNTech SE announced that Health Canada has authorized COMIRNATY® Original & Omicron BA.4/BA.5 as a 10-µg booster dose for children 5 through <12 years="" of="" age.="" this="" booster="" is="" approved="" for="" use="" at="" least="" 6="" months="" after="" completing="" the="" primary="" course="" of="" the="" companies'="" original="" covid-19="" vaccine="" (comirnaty).="" years="" of="" age.="" this="" booster="" is="" approved="" for="" use="" at="" least="" 6="" months="" after="" completing="" the="" primary="" course="" of="" the="" companies'="" original="" covid-19="" vaccine="">...
read more
Friday, December 09, 2022
Pfizer Inc. and BioNTech SE announced the companies have received Fast Track Designation from the FDA for their mRNA-based combination vaccine candidate for influenza and COVID-19, which aims to help ...
read more
Thursday, December 08, 2022
Novavax announced that Health Canada has approved a supplement to a New Drug Submission (sNDS) for Nuvaxovid™ (COVID-19 Vaccine (Recombinant protein, Adjuvanted)) (NVX-CoV2373) for active immunization...
read more
Friday, December 02, 2022
Hoffmann-La Roche Limited (Roche Canada) has signed agreements with the Government of Canada to supply 15,000 treatment courses of ACTEMRA ® IV (tocilizumab for injection) for adult patients ...
read more
Thursday, December 01, 2022
Novavax, Inc. announced that the World Health Organization (WHO) has issued an updated Emergency Use Listing (EUL) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent ...
read more
Thursday, December 01, 2022
The COVID-19 pandemic posed unprecedented challenges to the U.S. Food and Drug Administration’s (FDA) inspection program. Emergency public health measures, including global travel restrictions and ...
read more
Wednesday, November 23, 2022
Ascletis Pharma Inc. announced that the FDA approved the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for COVID...
read more
Monday, November 21, 2022
Novavax, Inc. announced that Health Canada has granted expanded authorization for Nuvaxovid™ (COVID-19 Vaccine (Recombinant protein, Adjuvanted)) (NVX-CoV2373) for active immunization to prevent ...
read more